The Full Wiki

More info on SKF-83,959

SKF-83,959: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

(Redirected to SKF-83959 article)

From Wikipedia, the free encyclopedia

SKF-83959
SKF-83959 structure.png
IUPAC name
Identifiers
CAS number
PubChem 24278699
SMILES
Properties
Molecular formula C18H20ClNO2
Molar mass 317.810 g/mol
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

SKF-83959 is a drug used in scientific research that acts as an atypical dopamine receptor D1 agonist, acting as an agonist at phosphatidylinositol-linked D1 receptors and D1/D2-heteromers, but an antagonist at other subtypes.[1][2][3][4][5][6][7][8]

References

  1. ^ Jin LQ, Goswami S, Cai G, Zhen X, Friedman E (April 2003). "SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain". Journal of Neurochemistry 85 (2): 378–86. PMID 12675914.  
  2. ^ Zhen X, Goswami S, Friedman E (April 2005). "The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959". Pharmacology, Biochemistry, and Behavior 80 (4): 597–601. doi:10.1016/j.pbb.2005.01.016. PMID 15820529.  
  3. ^ Zhang ZJ, Jiang XL, Zhang SE, Hough CJ, Li H, Chen JG, Zhen XC (2005). "The paradoxical effects of SKF83959, a novel dopamine D1-like receptor agonist, in the rat acoustic startle reflex paradigm". Neuroscience Letters 382 (1-2): 134–8. doi:10.1016/j.neulet.2005.03.001. PMID 15911136.  
  4. ^ Panchalingam S, Undie AS (2005). "Physicochemical modulation of agonist-induced [35s]GTPgammaS binding: implications for coexistence of multiple functional conformations of dopamine D1-like receptors". Journal of Receptor and Signal Transduction Research 25 (2): 125–46. doi:10.1080/10799890500184948. PMID 16149770.  
  5. ^ Rashid AJ, So CH, Kong MM, Furtak T, El-Ghundi M, Cheng R, O'Dowd BF, George SR (January 2007). "D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum". Proceedings of the National Academy of Sciences of the United States of America 104 (2): 654–9. doi:10.1073/pnas.0604049104. PMID 17194762.  
  6. ^ Kuroiwa M, Bateup HS, Shuto T, Higashi H, Tanaka M, Nishi A (November 2008). "Regulation of DARPP-32 phosphorylation by three distinct dopamine D1-like receptor signaling pathways in the neostriatum". Journal of Neurochemistry 107 (4): 1014–26. doi:10.1111/j.1471-4159.2008.05702.x. PMID 18823371.  
  7. ^ Liu J, Wang W, Wang F, Cai F, Hu ZL, Yang YJ, Chen J, Chen JG (August 2009). "Phosphatidylinositol-linked novel D(1) dopamine receptor facilitates long-term depression in rat hippocampal CA1 synapses". Neuropharmacology 57 (2): 164–71. doi:10.1016/j.neuropharm.2009.05.001. PMID 19465033.  
  8. ^ Zhang X, Zhou Z, Wang D, Li A, Yin Y, Gu X, Ding F, Zhen X, Zhou J (June 2009). "Activation of phosphatidylinositol-linked D1-like receptor modulates FGF-2 expression in astrocytes via IP3-dependent Ca2+ signaling". The Journal of Neuroscience : the Official Journal of the Society for Neuroscience 29 (24): 7766–75. doi:10.1523/JNEUROSCI.0389-09.2009. PMID 19535588.  
Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message